Please login to the form below

Why and how doctors should be involved in startups

Hiba Saleem of Doctorpreneurs, tells us about why and how we should be involving doctors in startups. When looking to involve doctors and medical students in startups, it is important to know what type and level of involvement they are looking for and what kind of capacity is available. Establishing ways for approaching clinicians is also useful. Hiba mentions how there is a large community of medical students who are very interested in startups and innovative; further they can provide useful clinical insight that can benefit a startup. Hiba also mentions how in the current system, it is a challenge for doctors to have a dual role: practising as a clinician as well as pursuing a career in innovating. Doctorpreneurs acts as a platform with a mission to make the world of innovation more accessible to aspiring entrepreneurs. They act as a support system and a community for advice to connect and accelerate those who are interested, along with reaching out to a range of healthcare professionals and non-healthcare professionals alike.

17th November 2016



Company Details

Brandcast Health

+44 (0)20 7291 5070

Contact Website

16-17 Little Portland Street

Latest content on this profile

Day 2 Round-up from the Giant Health Event
Robin gives a quick overview of day 2 of the Giant Health Event.
Brandcast Health
Why patient education is important in oncology
We talked to Dr Bettina Ryll of Melanoma Patient Network Europe about changes in melanoma treatment and how the added complexity of new treatments has changed how patients need to be informed.
Brandcast Health
CABOSUN trial of cabozantinib – could it change how we treat frontline renal-cell carcinoma?
In the CABOSUN trial, cabozantinib was compared to sunitinib in treatment naive poor and intermediate risk renal-cell carcinoma (RCC) patients.
Brandcast Health
No surprises: results from the ENGOT-OV16/NOVA trial of niraparib in ovarian cancer
The ENGOT-OV16/NOVA trial of niraparib was a randomized, double-blinded placebo study with women with relapsed platinum-sensitive high-grade ovarian cancer.
Brandcast Health
FALCON trial of fulvestrant for advanced breast cancer
The Phase III FALCON trial compared fulvestrant to anastrozole for hormone receptor-positive advanced breast cancer.
Brandcast Health
Overview of the GIANT Health Event
Shafi Ahmed, PhD, FRCS, Director of Virtual Medics and Medical and GIANT Event Co-chair, provides an overview of the GIANT Health Event.
Brandcast Health